Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISION trial of videolaryngoscopic intubation with versus without atracurium
2026-526824-29-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of atracurium and Placebo-COD Research Private Ltd (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: First-attempt intubation success. Planned start Oct 2026; status: authorised.
02
Drugs
atracuriumPlacebo-COD Research Private Ltd
Beyond the preview
Go deeper on 2026-526824-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-526824-29-00.